Real-World Health Care Expenditure in Hemophilia a Patients Using Standard and Extended Half-Life Recombinant Factor VIII Products
Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.957
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2017
Authors
Publisher
Elsevier BV